9 participants
This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-22
- Start Date:
- 2026-03-09
- Completion:
- 2027-01-20
Conditions
- Multiple Sclerosis
Interventions
- DRUG
No Results Yet